Saidi R F, Kennealey P T, Elias N, Kawai T, Hertl M, Farrell M, Goes N, Hartono C, Tolkoff-Rubin N, Cosimi A B, Ko D S C
Department of Surgery, Transplantation Unit, Massachusetts General Hospital, Boston, Massachusetts 02114, USA.
Transplant Proc. 2008 Dec;40(10):3413-7. doi: 10.1016/j.transproceed.2008.08.127.
There is a paucity of data on long-term outcomes of older kidney recipients. Our aim was to compare the early and long-term outcomes of deceased donor kidney transplantation in patients aged >or=60 years with outcomes in younger recipients.
From 1998 to 2005, we performed 271 deceased donor kidney transplants. There were 76 recipients (28.1%) >60 years old. Older candidates were carefully selected based on their physiologic, cardiac, and performance status. Demographic data, including clinical characteristics, early complications, mortality, and patient and graft survival rates, were collected and analyzed.
Older patients had comparable perioperative mortality and morbidity, incidence of delayed graft function (DGF), length of stay, and readmissions compared with younger patients. The rates of acute rejection and major infections were also comparable between the 2 study groups. Among older recipients, 25/76 (32.1%) patients received extended criteria donor kidneys compared with only 35/195 (17.9%) of younger patients (P < .001). Nevertheless, equivalent 1-, 3-, and 5-year allograft survival rates were observed in elderly and young patients; 91.5% versus, 92.5%, 78.5% versus 81.9%, and 75.6% versus 78.5%, respectively. Overall patient survival was also comparable in both groups.
Kidney transplantation in appropriately selected elderly recipients provides equivalent outcomes compared with those observed in younger patients. These observations support the notion that older recipients should not lose access to deceased donor kidney transplantation in the effort to achieve a perceived gain in social utility.
关于老年肾移植受者长期预后的数据较少。我们的目的是比较60岁及以上死者供肾肾移植患者的早期和长期预后与年轻受者的预后。
1998年至2005年,我们进行了271例死者供肾肾移植。有76例受者(28.1%)年龄大于60岁。根据老年候选者的生理、心脏和身体状况进行仔细挑选。收集并分析人口统计学数据,包括临床特征、早期并发症、死亡率以及患者和移植物存活率。
与年轻患者相比,老年患者围手术期死亡率和发病率、移植肾功能延迟恢复(DGF)发生率、住院时间和再入院率相当。两个研究组之间急性排斥反应和主要感染的发生率也相当。在老年受者中,25/76(32.1%)例患者接受了扩大标准供肾,而年轻患者中只有35/195(17.9%)例(P <.001)。然而,老年和年轻患者的1年、3年和5年同种异体移植物存活率相当;分别为91.5%对92.5%、78.5%对81.9%、75.6%对78.5%。两组患者的总体存活率也相当。
在经过适当挑选的老年受者中进行肾移植,其预后与年轻患者相当。这些观察结果支持这样一种观点,即在努力实现社会效用的预期收益时,老年受者不应被排除在死者供肾肾移植之外。